Page last updated: 2024-08-24

3-iodobenzylguanidine and tyrosine

3-iodobenzylguanidine has been researched along with tyrosine in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hasegawa, K; Kowa, H; Stoessl, AJ; Wszolek, ZK; Yagishita, S; Yokoyama, T1
Fukuda, T; Fukumitsu, N; Kiyono, Y; Suzuki, M1

Other Studies

2 other study(ies) available for 3-iodobenzylguanidine and tyrosine

ArticleYear
Familial parkinsonism: study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes.
    Parkinsonism & related disorders, 2009, Volume: 15, Issue:4

    Topics: 3-Iodobenzylguanidine; Adult; Aged; Aged, 80 and over; DNA Mutational Analysis; Family Health; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Isoleucine; Japan; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mutation; Parkinsonian Disorders; Positron-Emission Tomography; Protein Serine-Threonine Kinases; Radiopharmaceuticals; Tetrabenazine; Tyrosine

2009
Multipoint analysis of reduced (125)I-meta-iodobenzylguanidine uptake and norepinephrine turnover in the hearts of mice with 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine-induced parkinsonism.
    Nuclear medicine and biology, 2009, Volume: 36, Issue:6

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3-Iodobenzylguanidine; Animals; Dopamine; Mice; Myocardium; Neostriatum; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Parkinson Disease; Time Factors; Tyrosine

2009